Gamida Cell is an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. Gamida Cell is a publicly traded company (Nasdaq: GMDA).
Omidubicel, Gamida Cell’s lead investigational product candidate, is an advanced cell therapy under development as a potential life-saving allogeneic hematopoietic stem cell (bone marrow) transplant solution for patients with hematologic malignancies. Omidubicel is the first bone marrow transplant product to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration and has also received Orphan Drug Designation in the U.S. and EU. Omidubicel was evaluated in an international, multi-center, randomized Phase 3 study in patients with high-risk blood cancers, and positive primary and secondary endpoint data reported in 2020.
General Scope and Summary
Working with cross-functional teams and external collaborators, the Medical Director will take a leadership role in the creation and execution of clinical development plans, medical oversight and interactions with investigators and other critical clinical stakeholders. This is a hands-on role, both involved with providing strategic insights to advance clinical programs while also being able to develop and execute well-defined plans all while leading within a cross-functional organization where our values in action are prioritized.
Roles and Responsibilities
Experience, Education and Specialized Knowledge and Skills
Travel: Up to 25%, once travel resumes
Reports to: Vice President, Clinical development
To apply: Send resume and cover letter to firstname.lastname@example.org.